Stay updated on Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-10-03T05:46:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    0.5%
    Check dated 2024-09-25T23:23:12.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    0.4%
    Check dated 2024-09-18T17:18:00.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.0%
    Check dated 2024-09-04T06:28:09.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study results posted on August 14, 2024, detail the efficacy and safety of nemolizumab in treating moderate-to-severe atopic dermatitis after a 16-week treatment period, highlighting significant clinical response metrics such as IGA success and EASI-75 improvement.
    Difference
    98%
    Check dated 2024-08-21T02:00:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T01:06:16.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.